Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Bio-Rad Laboratories Q4 Adj. EPS $4.01 Beats $3.29 Estimate, Sales $757.90M Beat $686.80M Estimate


Benzinga | Feb 11, 2021 04:20PM EST

Bio-Rad Laboratories Q4 Adj. EPS $4.01 Beats $3.29 Estimate, Sales $757.90M Beat $686.80M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $4.01 per share which beat the analyst consensus estimate of $3.29 by 21.88 percent. This is a 72.84 percent increase over earnings of $2.32 per share from the same period last year. The company reported quarterly sales of $757.90 million which beat the analyst consensus estimate of $686.80 million by 10.35 percent. This is a 21.38 percent increase over sales of $624.43 million the same period last year.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC